Selected immunologic and biochemical risk factors of the retinopathy and nephropathy development in children with diabetes mellitus type 1;Wybrane czynniki immunologiczne i biochemiczne ryzyka rozwoju retinopatii i nefropatii cukrzycowej u dzieci z cukrzyca̧ typu 1

Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego

Volumn 12, Issue 4, 2006, Pages 269-273

  Myśliwiec, Małgorzata ^a   Balcerska, Anna ^a   Zorena, Katarzyna ^b   Myśliwska, Jolanta ^b   Nowacka, Mirosława ^c   Lipowski, Paweł ^d   Raczyńska, Krystyna ^d  

^a Klinika Pediatrii   (Poland)

^b Zaklad Immunologii   (Poland)

^c AM   (Poland)

^d Katedra I Klinika Chorób Oczu AM W Gda sku   (Poland)

Author keywords

Diabetes mellitus type 1; IL 6; NAG; Nephropathy; Retinopathy; TNF

Indexed keywords

C PEPTIDE; CYTOKINE; HEMOGLOBIN A1C; INTERLEUKIN 6; N ACETYLGLUCOSAMINE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ALBUMINURIA; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; EYE EXAMINATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; RISK FACTOR; SCHOOL CHILD; URINALYSIS;

EID: 33845918935     PISSN: 1234625X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Sochett E., Daneman D.: Early diabetes - related complacations in children and adolescents with type 1 diabetes. Endocrinol. Metab. Clin. North Am., 999, 28, 865-881.
2. Danne T., Kordonouri O., Endres I., Hovener G.: Monitoring for retinopathy in children and adolescents with type 1 diabetes. Acta Paediatr., 1998, 425, 35-41.
3. Early Treatment Diabetic Retinopathy Study Research Group: Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: Early Treatment Diabetic Retinopathy Study Report Number 19. Arch. Ophthalmol., 1995, 113, 1144-1155.
4. Królewski A.S., Warram J.H., Christlieb A.R. i wsp.: The changing natural history of nephropathy in type 1 diabetes. Am. J. Med., 1985, 78, 785-794.
5. Schram M.T., Chaturvedi N., Schalkwijk C. i wsp., EURODIAB Prospective Complications Study Group: Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes. The EURODIAB Prospective Complications Study. Diabetologia, 2005, 48, 370-378.
6. Schalkwijk C.G., Poland D.C.W., Emeis J.J. i wsp.: Plasma concentration of C-reactive protein is increased in type 1 diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia, 1999, 42, 351-357.
7. Visser M., Bouter L.M., McQuillan G.M. i wsp.: Elevated C-reactive protein levels in owerweight and obese adults. Jama, 1999, 282, 2131-2135.
8. Ferro D., Basili S., Roccoforte S.: Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus. Arthritis Rheum., 1999, 42, 2689-2697.
9. Zozulińska D., Wierusz-Wysocka B.: Rola zapalenia w patogenezie przewlekłych powikłań cukrzycy. Diabetol. Pol., 2004, 11, 264-267.
10. Funatsu H., Yamashita H., Noma H.: Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am. J. Ophthalmol., 2002, 133, 70-77.
11. Limb G.A., Soomro H., Janikoun S. i wsp.: Evidence for control of tumor necrosis factor-alpha (TNF-alpha) activity by TNF receptors in patients with proliferative diabetic retinopathy. Clin. Exp. Immunol., 999, 115, 409-414.
12. Wȩdrychowicz A., Dziatkowiak H., Sztefko K., Wȩdrychowicz A.: Interleukin-6 (IL-6) and IGF-IGFBP system in children and adolescents with type 1 diabetes mellitus. Exp. Clin. Endocrinol. Diabetes, 2004, 112, 435-439.
13. Shikano M., Sobajima H., Yoshikawa H. i wsp.: Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy. Nephron, 2000, 85, 81-85.
14. Schram M.T., Chaturvedi N., Schalkwijk C. i wsp.: Vascular risk factors and markers of endothelial function as markers of endothelial function as determinants of inflammatory markers in type 1 diabetes. The Eurodiab Prospective Complications Study. 2003, Diabetes Care, 26, 2165-2173.
15. Doganay S., Evereklioglu C., Turkoz E.R.H. i wsp.: Comparison of serum NO, TNFα, IL-1β, Sil-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye, 2002, 16, 163-170.
16. Hasegawa G., Nakano K., Sawada M. i wsp.: Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int., 1991, 40, 1007-1012.
17. Nakamura T., Fukui M., Ebihara I. i wsp.: mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes, 1993, 42, 450-6.
18. American Diabetes Association: Diagnosis and Classification of Diabetes. Diabetes Care, 1997, 20, 1183-1197 and Diabetes Care, 2003, 26, 3160-3167.
19. Wyszyńska T., Litwin M.: Nadciśnienie tȩtnicze u dzieci i młodzieży. Wydawnictwo Lekarskie PZWL, Warszawa 2002, 46.
20. ETDRS Report No 11. Classification of diabetic retinopathy from fluorescein angiograms ETDRS Research Group. Ophthalmology, 1991, 98, 807-822.
21. Myśliwiec M., Balcerska A., Kamińska H., Nowacka M.: Rola N-caetylo-beta-D-glukozaminidazy oraz izoenzymów A i B oznaczonych w surowicy krwi i w moczu we wczesnej diagnostyce nefropatii cukrzycowej - czȩść I. Diabetologia Polska, 2000, 7, 171-178; czȩść II: Diabetol. Pol., 2000, 7, 179-184.
22. Myśliwiec M., Balcerska A., Zorena K.: Badanie aktywności N-acetylo-beta-D-glukozanidazy oraz jego izoenzymów A i B w surowicy krwi i moczu jako wczesne wskaźniki rozwoju zmian naczyniowych w przebiegu cukrzycy typu 1. Nefrologia i Dializoterapia Polska, 2004, 8, 60-65.
23. Myśliwska J., Zorena K., Ba̧kowska A. i wsp.: Significance of tumor necrosis factor alpha in patients with standing type-I diabetes mellitus. Horm. Metab. Res., 1998, 3, 158-161.
24. Schulz C.J., Konopelska-Bahu T., Dalton R.N. i wsp.: Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Diabetes Care, 1999, 22, 495-502.
25. Shield J.P.H., Hunt L.P., Karachaliou F., Baum J.D.: Is microalbuminuria progressive? Arch. Dis. Child., 1995, 73, 512-513.
26. Lorini R., De Amici M., d'Annunizo G. i wsp.: Low serum levels of tumor necrosis factor-alpha in insulin-dependent diabetic children. Horm. Res., 1995, 43, 206-209.
27. Vitali L., De Amici M., d'Annunizo G. i wsp.: Low serum TNF-alpha levels in subjects at risk for type 1 diabetes. J. Pediatr. Endocrinol. Metab., 2000, 13, 475-481.
28. Hsiao P.H., Tsai W.S., Tsai W.Y., Lee J.S.: Urinary N-acetyl-beta-D-glucosaminidase activity in children with insulin-dependent diabetes mellitus. Am. J. Nephrol., 1996, 16, 300-303.
29. Kordonouri O., Hartmann R., Muller C. i wsp.: Predictive value of tubular markers for the development of microalbuminuria in adolescents with diabetes. Horm. Res., 1998, 50, 23-27.
30. Agard C.D., Agard E., Isacksson A.: Assocoation between urinary N-acetyl-beta-glucosaminidase and its isoenzyme patterns and microangiopathy in type 1 diabetes mellitus. Clin. Chem., 1991, 37, 696-699.
31. Targher G., Zenari L., Bertolini L. i wsp.: Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications. Diabetes Care, 2001, 24, 956-957.
32. Funatsu H., Yamashita H., Noma H.: Aqueous humor levels of cytokine are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes. Arch. Clin. Exp. Ophthalmol., 2005, 243, 3-8.
33. Chatterjee P.K., Hawksworth G.M., McLay J.S.: Cytokine-stimulated nitric oxide production in the human renal proximal tubule and its modulation by natriuretic peptides: a novel immunomodulatory mechanism? Exp. Nephrol., 1999, 7, 438-448.
34. Markewitz B.A., Michael J.R., Kohan D.E.: Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells. J. Clin. Incest., 1993, 91, 2138-2143.
35. McBride W.T., McBride S.J.: The balance of pro- and anti-inflammatory cytokines in cardiac surgery. Curr. Opin. Anaesth., 1998, 11, 15-22.
36. Inoue T., Matsunaga R., Morooka S., Uehara Y.: Serum N-acetyl-β-D-glucosaminidase activity increases in association with insulin resistance in patients with coronary artery disease. Atherosclerosis, 2000, 149, 117-122.
37. Yuuki T., Kanda T., Kimura Y., Kotajima N.: Inflammatory cytokines in vitreous fluid with diabetic vitreoretinopathy. J. Diabetes Complications, 2001, 15, 257-259.